MEMS® has been a part of successful adherence research for more than 30 years.
Download this adherence compendium and find out how digital medication adherence monitoring increases the impact of academic research findings.
Uncategorized
AARDEX Group and OnDosis Launch Collaboration to Bring Innovation to Drug Dosing in Clinical Trials
Liège, Belgium and Gothenburg, Sweden – October 15, 2024: AARDEX Group, a leader in managing drug exposure in clinical trials, and precision medicine innovators, and OnDosis, a game changer in precision dosing of oral solid medicines through the novel Dosage
Oksana Pidmogylna
October 15, 2024
